Genetically attenuated Trypanosoma cruzi parasites as a potential vaccination tool.
Chagas disease is the clinical manifestation of the infection produced by the parasite Trypanosoma cruzi. Currently there is no vaccine to prevent this disease and the protection attained with vaccines containing non-replicating parasites is limited. Genetically attenuated trypanosomatid parasites can be obtained by deletion of selected genes. Gene deletion takes advantage of the fact that this parasite can undergo homologous recombination between endogenous and foreign DNA sequences artificially introduced in the cells. This approach facilitated the discovery of several unknown gene functions, as well as allowing us to speculate about the potential for genetically attenuated live organisms as experimental immunogens. Vaccination with live attenuated parasites has been used effectively in mice to reduce parasitemia and histological damage, and in dogs, to prevent vector-delivered infection in the field. However, the use of live parasites as immunogens is controversial due to the risk of reversion to a virulent phenotype. Herein, we present our results from experiments on genetic manipulation of two T. cruzi strains to produce parasites with impaired replication and infectivity, and using the mutation of the dhfr-ts gene as a safety device against reversion to virulence.
Instituto de Patología Experimental-CONICET, Universidad Nacional de Salta, Salta, Argentina. cecilia.perezbrandan@conicet.gov.ar
Cecilia
C
Pérez Brandan
Miguel Ángel
MÁ
Basombrío
D000818:Animals; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D014355:Chagas Disease / Q000276:immunology / Q000469:parasitology / Q000517:prevention & control* / Q000635:transmission; D004285:Dogs; D017353:Gene Deletion; D005818:Genetic Engineering; D059765:Homologous Recombination; D051379:Mice; D009154:Mutation; D018512:Parasitemia / Q000276:immunology / Q000517:prevention & control*; D015800:Protozoan Proteins / Q000235:genetics* / Q000378:metabolism; D016052:Protozoan Vaccines / Q000008:administration & dosage / Q000235:genetics* / Q000276:immunology; D013762:Tetrahydrofolate Dehydrogenase / Q000235:genetics* / Q000378:metabolism; D014349:Trypanosoma cruzi / Q000201:enzymology / Q000235:genetics* / Q000276:immunology / Q000472:pathogenicity*; D014613:Vaccines, Attenuated; D014774:Virulence
D015800:Protozoan Proteins; D016052:Protozoan Vaccines; D014613:Vaccines, Attenuated; D013762:Tetrahydrofolate Dehydrogenase